The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksElementis Regulatory News (ELM)

Share Price Information for Elementis (ELM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.40
Bid: 147.80
Ask: 148.40
Change: 0.00 (0.00%)
Spread: 0.60 (0.406%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 147.40
ELM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Statement

25 Apr 2017 07:00

ELEMENTIS PLC - AGM Trading Statement

ELEMENTIS PLC - AGM Trading Statement

PR Newswire

London, April 24

25 April 2017

AGM / Trading Statement

A positive start to the year with trading strong across the businesses.

Ahead of today’s Annual General Meeting, Elementis plc (ELM.L, the “Company" or the “Group"), the Global Specialty Chemicals Company, today issues its trading update for the three months ended 31 March 2017.Trading for the Group in the first quarter (Q1) was underpinned by stronger demand across most of our markets compared to Q1 2016. In Specialty Products, our Coatings business sector started well and we saw notably strong growth in our Personal Care and Energy business sectors. In our Chromium segment there were some indications of improved demand outside North America. In Surfactants we are benefiting from short term favourable pricing conditions which are not expected to continue indefinitely. This represents a positive start to the year and we remain on track to grow operating profit across our three segments in 2017.On 20 March 2017, we announced the sale of our non-core US colourants business and the closure of our Jersey City facility as part of our strategy to review our non-core and disadvantaged assets. On 24 March 2017, we completed our acquisition of SummitReheis and have started the integration process. It is a high quality business and we are delighted to have it in our portfolio. Commenting on the Company’s performance Paul Waterman, CEO, said: “We are off to a good start in 2017 as trading was strong across our businesses. Last November we committed to reignite growth at Elementis by focusing on four strategic priorities: pursuing the best growth opportunities, transforming our global supply chain, innovating for distinctiveness and high margins and creating a culture of high performance. We are excited to integrate SummitReheis into our Personal Care sector and look forward to completing this by the end of the year. Overall, while uncertainties exist we believe continued focus on implementing our strategy will underpin continued progress in 2017.” ENDS

Enquiries:

Elementis+ 44 (0) 207 067 2999
Paul Waterman, Chief Executive Officer Ralph Hewins, Chief Financial Officer
FTI Consulting+ 44 (0) 203 727 1000
Deborah Scott
Matthew Cole
Date   Source Headline
14th Mar 20237:30 amRNSDirector Declaration
9th Mar 20232:50 pmRNSDirector/PDMR Shareholding
9th Mar 20232:47 pmRNSDirector/PDMR Shareholding
7th Mar 20237:00 amRNSPreliminary results year ended 31 December 2022
1st Mar 20239:53 amRNSBlock listing Interim Review
1st Mar 20239:39 amRNSTotal Voting Rights
31st Jan 20233:04 pmRNSSale of Chromium business
19th Jan 20237:00 amRNSTrading Update
3rd Jan 20239:47 amRNSTotal Voting Rights
8th Dec 20222:10 pmRNSDirector/PDMR Shareholding
30th Nov 20227:00 amRNSSale of Chromium business
23rd Nov 20223:54 pmRNSHolding(s) in Company
16th Nov 20221:43 pmRNSHolding(s) in Company
10th Nov 20229:40 amRNSHolding(s) in Company
10th Nov 20227:00 amRNSDirectorate Change
1st Nov 20229:48 amRNSTotal Voting Rights
31st Oct 20223:23 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSQ3 Trading Update
18th Oct 20223:13 pmRNSHolding(s) in Company
3rd Oct 20229:39 amRNSTotal Voting Rights
29th Sep 202212:45 pmRNSDirector/PDMR Shareholding
29th Sep 202210:12 amRNSDirector/PDMR Shareholding
22nd Sep 202211:17 amRNSDirector/PDMR Shareholding
21st Sep 20224:58 pmRNSDirector/PDMR Shareholding
21st Sep 20223:48 pmRNSDirector/PDMR Shareholding
6th Sep 202212:52 pmRNSDirector Declaration
5th Sep 20224:14 pmRNSAdditional Listing
1st Sep 202212:39 pmRNSHolding(s) in Company
1st Sep 20229:15 amRNSBlock listing Interim Review
1st Sep 20229:00 amRNSTotal Voting Rights
2nd Aug 20227:00 amRNSHalf-year Report
1st Aug 202211:08 amRNSTotal Voting Rights
21st Jul 20223:14 pmRNSHolding(s) in Company
1st Jul 20229:47 amRNSTotal Voting Rights
20th Jun 20221:54 pmRNSHolding(s) in Company
17th Jun 20224:35 pmRNSPrice Monitoring Extension
3rd May 202210:27 amRNSTotal Voting Rights
3rd May 20227:00 amRNSCompany Secretary Change
26th Apr 202212:28 pmRNSResult of AGM
26th Apr 20227:00 amRNSAGM Trading Statement
5th Apr 20224:17 pmRNSDirector/PDMR Shareholding
23rd Mar 20223:52 pmRNSAdditional Listing
22nd Mar 20224:18 pmRNSAnnual Financial Report & Notice of AGM
15th Mar 20227:53 amRNSDirectorate Change
8th Mar 202212:18 pmRNSDirector/PDMR Shareholding
8th Mar 202212:17 pmRNSDirector/PDMR Shareholding
8th Mar 202211:47 amRNSHolding(s) in Company
8th Mar 202210:43 amRNSDirector/PDMR Shareholding
8th Mar 202210:39 amRNSDirector/PDMR Shareholding
7th Mar 20223:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.